Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (8,637,316)	$ (4,827,314)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	42,213	26,806
Warrant issued for technology license	0	209,825
Gain on debt extinguishment	0	(172,056)
Changes in assets and liabilities:
Grant funds and other receivables	49,006	182,663
Prepaid expenses and other current assets	(1,251,539)	106,979
Deposits and other assets	(2,173,276)	0
Accounts payable and accrued expenses	(645,955)	(289,477)
Total adjustments	(3,328,656)	314,043
Net cash used in operating activities	(11,965,972)	(4,513,271)
Cash flows from investing activities
Purchase of equipment	(134,258)	(47,718)
Net cash used in investing activities	(134,258)	(47,718)
Cash flows from financing activities:
Net proceeds from sale of common stock and warrants	27,727,194	9,408,920
Net proceeds from warrant exercises	7,626,134	3,404,156
Repurchase of preferred stock	0	(1,000)
Principal repayment of note payable	0	(27,864)
Net cash provided by financing activities	35,353,328	12,784,212
Net increase in cash and cash equivalents	23,253,098	8,223,223
Cash and cash equivalents at beginning of period	11,423,870	9,883,796
Cash and cash equivalents at end of period	34,676,968	18,107,019
Employees and Directors [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	570,573	168,570
Consultants [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	$ 80,322	$ 80,733